NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,986 | -2.6% | 24,860 | 0.0% | 0.15% | 0.0% |
| Q2 2023 | $184,710 | +7.2% | 24,860 | 0.0% | 0.15% | -5.1% |
| Q1 2023 | $172,280 | -32.6% | 24,860 | 0.0% | 0.16% | -41.4% |
| Q4 2022 | $255,561 | -41.1% | 24,860 | +4.3% | 0.27% | -47.7% |
| Q3 2022 | $434,000 | -64.6% | 23,835 | 0.0% | 0.51% | -62.9% |
| Q2 2022 | $1,226,000 | +21.6% | 23,835 | +74.1% | 1.37% | +44.0% |
| Q1 2022 | $1,008,000 | -33.6% | 13,689 | +29.0% | 0.95% | -31.6% |
| Q4 2021 | $1,519,000 | – | 10,614 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |